Brief: Pharma Equity Group Announces Preliminary Data From First Part Of Clinical Study In Pouchitis
June 8 (Reuters) - Pharma Equity Group A/S PEGRP.CO :
* REG-ENCOURAGING PRELIMINARY DATA FROM THE FIRST PART OF A
CLINICAL STUDY IN POUCHITIS
* WE OBSERVED 5 OUT OF 6 PATIENTS WITH IMPROVEMENT IN
POUCHITIS
DISEASE ACTIVITY INDEX (PDAI) TOTAL SCORE
Source text for Eikon: ID:nGNE6HCTQT
Further company coverage: PEGRP.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations